These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22701760)

  • 1. The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration.
    Cook DR; Solski PA; Bultman SJ; Kauselmann G; Schoor M; Kuehn R; Friedman LS; Cowley DO; Van Dyke T; Yeh JJ; Johnson L; Der CJ
    Genes Cancer; 2011 Oct; 2(10):932-42. PubMed ID: 22701760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis.
    Tatsumoto T; Xie X; Blumenthal R; Okamoto I; Miki T
    J Cell Biol; 1999 Nov; 147(5):921-8. PubMed ID: 10579713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase-δ-interacting protein 2 activates the RhoGEF epithelial cell transforming sequence 2 in vascular smooth muscle cells.
    Huff LP; Kikuchi DS; Faidley E; Forrester SJ; Tsai MZ; Lassègue B; Griendling KK
    Am J Physiol Cell Physiol; 2019 May; 316(5):C621-C631. PubMed ID: 30726115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.
    Saito S; Tatsumoto T; Lorenzi MV; Chedid M; Kapoor V; Sakata H; Rubin J; Miki T
    J Cell Biochem; 2003 Nov; 90(4):819-36. PubMed ID: 14587037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for C-terminal sequences in regulation of Ect2 guanine nucleotide exchange specificity and transformation.
    Solski PA; Wilder RS; Rossman KL; Sondek J; Cox AD; Campbell SL; Der CJ
    J Biol Chem; 2004 Jun; 279(24):25226-33. PubMed ID: 15073184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tandem BRCT domains of Ect2 are required for both negative and positive regulation of Ect2 in cytokinesis.
    Kim JE; Billadeau DD; Chen J
    J Biol Chem; 2005 Feb; 280(7):5733-9. PubMed ID: 15545273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel functions of Ect2 in polar lamellipodia formation and polarity maintenance during "contractile ring-independent" cytokinesis in adherent cells.
    Kanada M; Nagasaki A; Uyeda TQ
    Mol Biol Cell; 2008 Jan; 19(1):8-16. PubMed ID: 17942602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
    Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
    Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of p190RhoGAP and Ect2 RhoGEF in regulating cytokinesis.
    Mikawa M; Su L; Parsons SJ
    Cell Cycle; 2008 Jul; 7(13):2003-12. PubMed ID: 18642445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Non-canonical BRCT-Phosphopeptide Recognition Mechanism Underlies RhoA Activation in Cytokinesis.
    Gómez-Cavazos JS; Lee KY; Lara-González P; Li Y; Desai A; Shiau AK; Oegema K
    Curr Biol; 2020 Aug; 30(16):3101-3115.e11. PubMed ID: 32619481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation.
    Saito S; Liu XF; Kamijo K; Raziuddin R; Tatsumoto T; Okamoto I; Chen X; Lee CC; Lorenzi MV; Ohara N; Miki T
    J Biol Chem; 2004 Feb; 279(8):7169-79. PubMed ID: 14645260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
    Justilien V; Fields AP
    Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.
    Huff LP; Decristo MJ; Trembath D; Kuan PF; Yim M; Liu J; Cook DR; Miller CR; Der CJ; Cox AD
    Genes Cancer; 2013 Nov; 4(11-12):460-75. PubMed ID: 24386507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of the RhoGEF Ect2 to the equatorial membrane controls cleavage furrow formation during cytokinesis.
    Su KC; Takaki T; Petronczki M
    Dev Cell; 2011 Dec; 21(6):1104-15. PubMed ID: 22172673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition.
    Scoumanne A; Chen X
    Cancer Res; 2006 Jun; 66(12):6271-9. PubMed ID: 16778203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a Rho guanine nucleotide exchange factor, Ect2, in the developing mouse pituitary.
    Islam MS; Tsuji T; Higashida C; Takahashi M; Higashida H; Koizumi K
    J Neuroendocrinol; 2010 May; 22(5):477-82. PubMed ID: 20141573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA.
    Reuther GW; Lambert QT; Booden MA; Wennerberg K; Becknell B; Marcucci G; Sondek J; Caligiuri MA; Der CJ
    J Biol Chem; 2001 Jul; 276(29):27145-51. PubMed ID: 11373293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dbl family RhoGEFs in cancer: different roles and targeting strategies.
    Chen XY; Cheng AY; Wang ZY; Jin JM; Lin JY; Wang B; Guan YY; Zhang H; Jiang YX; Luan X; Zhang LJ
    Biochem Pharmacol; 2024 May; 223():116141. PubMed ID: 38499108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC(cdh1) mediates degradation of the oncogenic Rho-GEF Ect2 after mitosis.
    Liot C; Seguin L; Siret A; Crouin C; Schmidt S; Bertoglio J
    PLoS One; 2011; 6(8):e23676. PubMed ID: 21886810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth.
    Cook DR; Kang M; Martin TD; Galanko JA; Loeza GH; Trembath DG; Justilien V; Pickering KA; Vincent DF; Jarosch A; Jurmeister P; Waters AM; Hibshman PS; Campbell AD; Ford CA; Keku TO; Yeh JJ; Lee MS; Cox AD; Fields AP; Sandler RS; Sansom OJ; Sers C; Schaefer A; Der CJ
    Cancer Res; 2022 Jan; 82(1):90-104. PubMed ID: 34737214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.